Skip to content

Clozapine evidence in older adults leaves major gaps for long-term users

Observational reports described benefits, but a small controlled comparison did not establish superiority over chlorpromazine. Evidence about adapting established treatment as people age was absent.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

For people aged 50 or older with severe mental illness, observational studies reported clozapine benefits, while a small controlled study did not establish superiority over chlorpromazine. Identified risks included pneumonia involving inhaled material, constipation, blood-pressure drops on standing, and falls. Evidence on adapting treatment for established users as they grow older was absent.

Keep in mind

Few studies used structured assessments of benefit. This abstract-based account therefore cannot establish effectiveness from the observational reports, and the small controlled comparison does not demonstrate equivalence between the medications.

Different evidence gives different answers

Most evidence came from reviews of medical records, which reported benefits without consistently using structured assessments. The controlled comparison did not find clozapine superior, leaving a gap between reported clinical impressions and stronger comparative evidence.

Safety and aging gaps

No reported death was attributed to clozapine, but that absence does not establish safety. Most studies concerned new users; none examined adapting established treatment as long-term users reached older age, despite the adverse risks identified.

CHECK THE ORIGINAL

The original publication

Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice.

Verdoux H, Lepetit A, de Leon J
Expert Rev Clin Pharmacol · 2025

PubMed ID
40515647
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.